Erlotinib in patients with advanced lung squamous cell carcinoma

Author： Chiang Chi-Lu Tsai Chun-Ming Chou Teh-Ying Chen Yuh-Min Lai Shinn-Liang Shih Jen-Fu Chiu Chao-Hua Lee Yu-Chin

ISSN： 0344-5704

Source： Cancer Chemotherapy and Pharmacology, Vol.71, Iss.1, 2013-01, pp. : 203-208

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Erlotinib and Gefitinib for Elderly Patients with Advanced Non-small-cell Lung Cancer

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 14, Iss. 5, 2014-06 ,pp. : 646-650

Bentham Science Publishers

Access to resources Recommend Favorite

Comparison of Induction Chemotherapy Before Radiotherapy with Radiotherapy Only in Patients with Locally Advanced Squamous Cell Carcinoma of the Lung

By Brodin O. Nou E. Mercke C. Linden C.J. Lundstrom R. Arwidi A. Brink J. Ringborg U.

European Journal of Cancer, Vol. 32, Iss. 11, 1996-10 ,pp. : 1893-1900

Elsevier

Access to resources Recommend Favorite

Targeted Therapies for Locally Advanced or Metastatic Squamous Cell Carcinoma of the Lung

By Stinchcombe Thomas

Current Treatment Options in Oncology, Vol. 14, Iss. 4, 2013-12 ,pp. : 568-579

Springer Publishing Company

Access to resources Recommend Favorite

Efficacy and safety of first-line erlotinib in elderly patients with advanced non-small cell lung cancer

Oncology Reports, Vol. 28, Iss. 2, 2012-01 ,pp. : 721-727

Spandidos Publications

Access to resources Recommend Favorite

Erlotinib as second-line treatment in patients with advanced non-small-cell lung cancer and asymptomatic brain metastases: a phase II study (CTONG0803)

By Wu Y.-L. Zhou C. Cheng Y. Lu S. Chen G.-Y. Huang C. Huang Y.-S. Yan H.-H. Ren S. Liu Y. Yang J.-J.

Annals of Oncology, Vol. 24, Iss. 4, 2013-04 ,pp. : 993-999

Oxford University Press

Access to resources Recommend Favorite